Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

166.05
+1.400.85%
Post-market: 166.050.00000.00%16:56 EDT
Volume:315.57K
Turnover:51.91M
Market Cap:9.94B
PE:-24.56
High:166.86
Open:164.29
Low:161.01
Close:164.65
Loading ...
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities